How Often Is Vaginal Leukoplakia Cancer? Warning Signs
At a Glance
Vaginal leukoplakia is a description of a white patch, not a cancer diagnosis, so there is no reliable cancer percentage for every case. A persistent or suspicious patch needs clinical examination and usually biopsy to identify benign, precancerous, or invasive disease.
In this answer
3 sections
When you see or hear the term “leukoplakia,” it is natural to worry about cancer. Waiting for answers can be frightening, but the purpose of a medical exam is to find the true cause, not to assume a white patch is cancer.
It is impossible to give a reliable percentage for how often vaginal leukoplakia is cancer because “leukoplakia” is not a specific diagnosis [1]. It simply describes a white patch on the mucous membranes. Because studies combine many different diseases that cause these white patches, the medical literature does not provide a single cancer risk rate [2][3]. It is also important to clarify that the vagina is the internal canal; the external area is the vulva, which has different causes for white patches.
A white patch inside the vagina can have benign (harmless), precancerous, or malignant (cancerous) causes, and its appearance alone cannot determine which it is. While biopsy is the usual definitive test to identify the cause, a persistent or suspicious patch always requires clinical review [4][5].
What Could the White Patch Be?
A white patch in the vagina can be caused by several different conditions:
- Inflammatory or Infectious Conditions: Sometimes a white area is a reaction to chronic inflammation, irritation, or an infection like a yeast infection [6]. While common irritation is not cancer, persistent or atypical inflammatory lesions still need medical review to confirm the diagnosis and ensure they aren’t hiding something more serious.
- Low-Grade VaIN (VaIN 1): VaIN (Vaginal Intraepithelial Neoplasia) means there are abnormal cells on the surface lining of the vagina. Low-grade VaIN is a mild change, often caused by HPV (Human Papillomavirus, a common virus). It is very unlikely to become cancer and frequently clears up on its own without treatment [7].
- High-Grade VaIN (VaIN 2 and VaIN 3): This is considered a “pre-cancer.” It is not invasive cancer, but the cells have a higher risk of turning into cancer. In specific medical studies following patients who received treatment for high-grade VaIN, between 5.8% and 7.1% progressed to invasive cancer over several years [7][8]. This is an average from studies, not an individual prediction, but it shows why high-grade VaIN requires treatment or close specialist management.
- Invasive Squamous Cell Carcinoma (SCC): SCC is the most common type of vaginal cancer. “Invasive” means abnormal cells have grown beyond the surface layer and into the deeper supporting tissue (stromal invasion) [4]. While progression to invasive cancer is uncommon overall, studies of patients who had surgical removal of high-grade VaIN found “occult” (hidden) invasive cancer already present in about 4.6% to 10.3% of the removed tissue samples [9].
It is worth noting that there is no routine screening program for vaginal cancer. VaIN is usually “silent” (causing no symptoms) and is often discovered when investigating an abnormal cervical Pap smear or HPV test, rather than by a patient noticing a white patch [10][11]. An abnormal cervical test does not diagnose vaginal cancer, but it may prompt your doctor to examine the vagina closely.
Warning Signs: What Warrants Prompt Assessment
Certain visual features and physical symptoms should prompt a timely medical evaluation. However, having these symptoms does not automatically mean you have cancer—they can also occur with benign inflammation, infection, or trauma. Conversely, early cancer may have no symptoms at all.
Visual and Physical Features
Doctors look for changes in the texture and shape of the tissue, such as:
- A firm mass or a hard, solid lump [12].
- Irregular thickening or a raised, outward-growing plaque [13][14].
- Ulceration, which looks like a persistent open sore or crater that does not heal [15].
Symptoms You Might Experience
Tell your doctor promptly if you experience:
- Spontaneous or unexplained bleeding, especially bleeding after sex or after menopause [14].
- A new, persistent watery or foul-smelling vaginal discharge [14].
- Pain in the pelvic area or pain during intercourse (dyspareunia) [12].
Do not wait for a routine screening if you experience unexplained bleeding or a new mass; contact your clinician promptly.
Why Visual Inspection Is Not Enough and What Happens Next
An area of harmless chronic inflammation can sometimes look similar to early invasive cancer, and both can present as white patches [6][13]. Therefore, a visual examination cannot reliably diagnose or rule out cancer.
If your doctor sees a persistent or suspicious white patch, they will likely recommend:
- Colposcopy: Using a special magnifying instrument to look closely at the vaginal walls [4].
- Biopsy: Taking a small sample of tissue. This usually involves a local anesthetic to numb the area. You may experience short-term spotting or mild discomfort afterward.
- Pathology: A specialist looks at the cells under a microscope to check for stromal invasion or other specific causes [5].
While a biopsy is the standard way to find the underlying cause, sometimes a small or superficial biopsy can miss a hidden area of deeper invasion. If the sample is inadequate or the doctor remains concerned, a larger excisional biopsy or repeat test may be needed.
Common questions in this guide
Is vaginal leukoplakia itself a cancer diagnosis?
How often does a vaginal white patch turn out to be cancer?
What changes in a vaginal white patch can suggest invasive cancer?
How is vaginal leukoplakia checked for cancer?
Is VaIN the same as vaginal cancer?
Does an abnormal Pap or HPV test mean I have vaginal cancer?
Related questions
Show more
Get notified when new evidence is published on leukoplakia of vagina.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Oral leukoplakia, the ongoing discussion on definition and terminology.
van der Waal I
Medicina oral, patologia oral y cirugia bucal 2015; (20(6)):e685-92 doi:10.4317/medoral.21007.
PMID: 26449439 - 2
First Reported Case of Invasive Cervical Squamous Cell Carcinoma Arising From an HPV 42-associated Seborrhoeic Keratosis-like Lesion of the Cervix and Vagina.
Gardner K, Bryson G, Smith D, et al.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2026; doi:10.1097/PGP.0000000000001170.
PMID: 41875374 - 3
Vulvar Neurodermatitis in a Postmenopausal African-American Patient: A Case Report.
Sanchez A, Gandhi K, Lee B, et al.
Journal of menopausal medicine 2022; (28(1)):42-45 doi:10.6118/jmm.21032.
PMID: 35534430 - 4
Cancer of the vagina.
Adams TS, Cuello MA
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2018; (143 Suppl 2()):14-21 doi:10.1002/ijgo.12610.
PMID: 30306589 - 5
Rare case of primary HPV negative vaginal cancer presenting in a young woman with normal cervix.
Carter E, Nguyen-Guo T, Guta P, et al.
Gynecologic oncology reports 2026; (63()):102032 doi:10.1016/j.gore.2026.102032.
PMID: 41623323 - 6
[Preliminary study of the clinical value of colposcopy in diagnosing vagina invasion in cervical cancer].
Zhu YL, Zhang WH, Liu BB, et al.
Zhonghua fu chan ke za zhi 2020; (55(5)):322-326 doi:10.3760/cma.j.cn112141-20200211-00093.
PMID: 32464720 - 7
High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV).
Sopracordevole F, Barbero M, Clemente N, et al.
European review for medical and pharmacological sciences 2016; (20(5)):818-24.
PMID: 27010135 - 8
The Progression of Vaginal Intraepithelial Neoplasia to Cancer: A Systematic Review and Meta-Analysis.
Indraccolo U, Favilli A
Journal of women's health (2002) 2026; (35(8)):781-789 doi:10.1177/15409996261438757.
PMID: 41943441 - 9
Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.
Sopracordevole F, De Piero G, Clemente N, et al.
Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.
PMID: 26461231 - 10
Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
Yu D, Qu P, Liu M
The journal of obstetrics and gynaecology research 2021; (47(5)):1624-1630 doi:10.1111/jog.14733.
PMID: 33754436 - 11
Screening History in Vaginal Precancer and Cancer: A Retrospective Study of 2131 Cases in China.
Zhang L, Wang Q, Zhang H, et al.
Cancer management and research 2021; (13()):8855-8863 doi:10.2147/CMAR.S335701.
PMID: 34858059 - 12
Primary vaginal squamous cell carcinoma-the coeffect of vaginal leiomyoma and Human papillomavirus (HPV); A case report.
Mavili HS, Kandiloğlu AR, Atmış Ö, Uyar Y
Journal of cancer research and therapeutics 2024; (20(5)):1622-1624 doi:10.4103/jcrt.jcrt_2108_22.
PMID: 39412933 - 13
Primary Invasive Squamous Cell Carcinoma of the Vagina Presenting Three Decades After Total Hysterectomy for Benign Endometriosis: A Case Report.
McKenna T, Pfeifer K, Tiberi A, Torres WI
Cureus 2025; (17(10)):e95242 doi:10.7759/cureus.95242.
PMID: 41281057 - 14
Management of Vaginal Cancer.
Shrivastava SB, Agrawal G, Mittal M, Mishra P
Reviews on recent clinical trials 2015; (10(4)):289-97 doi:10.2174/1574887110666150923112958.
PMID: 26411952 - 15
Primary vaginal squamous cell carcinoma with bladder involvement in uterine prolapsed patient: Case report.
Fedus T, Raś R, Książek M, et al.
Medicine 2017; (96(50)):e8993 doi:10.1097/MD.0000000000008993.
PMID: 29390294
This page is for informational purposes only and does not constitute medical advice. A gynecologist should evaluate any persistent, suspicious, or symptomatic vaginal white patch.